Jeffrey Scott Sherman - Dec 7, 2023 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Chief Financial Officer
Signature
/s/ Ali Olivo, Attorney-in-Fact
Stock symbol
NEO
Transactions as of
Dec 7, 2023
Transactions value $
$0
Form type
4
Date filed
12/11/2023, 07:54 PM
Previous filing
May 15, 2023
Next filing
Feb 27, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Tax liability $0 -8.15K -6.09% $0.00 126K Dec 7, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NEO Stock Option (Right to Buy) 249K Dec 7, 2023 Common Stock 249K $11.62 Direct F2
holding NEO Stock Option (Right to Buy) 73K Dec 7, 2023 Common Stock 73K $19.65 Direct F3
holding NEO Restricted Stock Unit 39K Dec 7, 2023 Common Stock 39K $0.00 Direct F4, F5
holding NEO Performance Stock Unit 39K Dec 7, 2023 Common Stock 39K $0.00 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the December 7, 2023 vesting of restricted stock.
F2 On December 5, 2022, Mr. Sherman was granted 249,169 stock options. These awards vest ratably over four years with the first tranche vesting on December 7, 2023.
F3 On May 11, 2023, Mr. Sherman was granted 73,016 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F4 On May 11, 2023, Mr. Sherman was granted 39,016 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
F5 Once vested, the shares of common stock are not subject to expiration.
F6 On May 11, 2023, Mr. Sherman was granted 39,016 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 58,524. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company.